"PIM" Designation For DCVax-L Is First Step In 2-Step Process for Early Access Approval BETHESDA, MD, September 16, 2014 – Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback